TMEM217 and acute myeloid leukemia: To explore the potential biological functions of TMEM217 in AML, two shRNAs targeting TMEM217 were designed and stably transfected two AML cell lines: HL60 (derived from AML-M2) and MOLM13 (derived from AML-M5) (Fig. S5A, B).